Logo image of BWAQ

BLUE WORLD ACQUISITION CORP (BWAQ) Stock Fundamental Analysis

NASDAQ:BWAQ - Nasdaq - KYG1263E1026 - Common Stock - Currency: USD

4.24  -4.46 (-51.26%)

After market: 2.78 -1.46 (-34.43%)

Fundamental Rating

1

Taking everything into account, BWAQ scores 1 out of 10 in our fundamental rating. BWAQ was compared to 0 industry peers in the Unkown industry. BWAQ may be in some trouble as it scores bad on both profitability and health. BWAQ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

BWAQ had positive earnings in the past year.
In the past year BWAQ has reported a negative cash flow from operations.
BWAQ Yearly Net Income VS EBIT VS OCF VS FCFBWAQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 1M 2M

1.2 Ratios

Industry RankSector Rank
ROA 5%
ROE 5.8%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BWAQ Yearly ROA, ROE, ROICBWAQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 1 -1 2 3

1.3 Margins

BWAQ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BWAQ Yearly Profit, Operating, Gross MarginsBWAQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

1

2. Health

2.1 Basic Checks

BWAQ has less shares outstanding than it did 1 year ago.
The debt/assets ratio for BWAQ is higher compared to a year ago.
BWAQ Yearly Shares OutstandingBWAQ Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2M 4M 6M 8M 10M
BWAQ Yearly Total Debt VS Total AssetsBWAQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of 0.86, we must say that BWAQ is in the distress zone and has some risk of bankruptcy.
BWAQ has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 0.86
ROIC/WACCN/A
WACCN/A
BWAQ Yearly LT Debt VS Equity VS FCFBWAQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.05 indicates that BWAQ may have some problems paying its short term obligations.
BWAQ has a Quick Ratio of 0.05. This is a bad value and indicates that BWAQ is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
BWAQ Yearly Current Assets VS Current LiabilitesBWAQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 500K 1M 1.5M 2M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 464.58% over the past year.
EPS 1Y (TTM)464.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.42%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BWAQ Yearly Revenue VS EstimatesBWAQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023
BWAQ Yearly EPS VS EstimatesBWAQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

1

4. Valuation

4.1 Price/Earnings Ratio

BWAQ is valuated rather expensively with a Price/Earnings ratio of 18.43.
BWAQ's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.63.
Industry RankSector Rank
PE 18.43
Fwd PE N/A
BWAQ Price Earnings VS Forward Price EarningsBWAQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BWAQ Per share dataBWAQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BWAQ!.
Industry RankSector Rank
Dividend Yield N/A

BLUE WORLD ACQUISITION CORP

NASDAQ:BWAQ (7/1/2024, 8:23:15 PM)

After market: 2.78 -1.46 (-34.43%)

4.24

-4.46 (-51.26%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners68.59%
Ins Owner Change0%
Market Cap11.74M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.43
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.32
P/tB 0.32
EV/EBITDA N/A
EPS(TTM)0.23
EY5.42%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS0
BVpS13.24
TBVpS13.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5%
ROE 5.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z 0.86
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)464.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.42%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-333.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-333.33%
OCF growth 3YN/A
OCF growth 5YN/A